Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

terminated133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruiting

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

NCT07256418
recruitingnot_applicable

Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions

NCT05927272
terminated

Serotoninergic Pathways in Sudden and Unexpted Death in Epilepsy (SUDEP)

NCT02788318

Clinical Trials (3)

Showing 3 of 3 trials
NCT07256418

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Recruiting
NCT05927272Not Applicable

Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions

Recruiting
NCT02788318

Serotoninergic Pathways in Sudden and Unexpted Death in Epilepsy (SUDEP)

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3